Grid Biosciences is a biotech company developing (1) cancer vaccines, utilizing frontrunner immunotherapy and vaccine technologies. (2) Its bio manufacturing technology is developed by its Nobel Laureate advisor, enabling scaleable manufacturing infrastructure. Grid's pipeline includes vaccines/drugs for global cancers as well as cancers tied to Asian populations. (3) Further, Grid's AI platform discovers and designs unique cancer precision medicine based on a patient's own cancer DNA sequence.